Boris Cherny was asked at Brainstorm Tech if he was concerned about the rapid progress of AI: "Yes." ...
Ongoing research into AI agent framework security identified an exploit chain in AutoGen Studio (AutoGen’s open-source prototyping user interface) that allows untrusted web content rendered by a ...
Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
This week’s cybersecurity recap covers Firefox and Chrome bugs, EDR-killer tools, a TV botnet, an OpenBSD flaw, Android ...
Six Proto6 flaws in protobuf.js enable RCE and DoS attacks; patched in versions 7.5.6 and 8.0.2 to protect Node.js services.
RXRX is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of RXRX shares has increased $0.12 since the market last closed. This is a 3.86 ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
States across the country are moving ahead with artificial intelligence regulations despite President Donald Trump's efforts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results